<DOC>
	<DOC>NCT00953173</DOC>
	<brief_summary>A prospective, international, multi-center study of clinical outcomes and estimated healthcare resource expenditures associated with the treatment of obesity using the LAP-BAND AP® Adjustable Gastric Banding System.</brief_summary>
	<brief_title>HERO Study: Helping Evaluate Reduction in Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<criteria>Patient and investigator have made a decision, independent of the study, to proceed with LAPBAND AP® implantation. Male or female aged ≥ 18 years. BMI ≥ 40 or a BMI ≥ 35 with one or more severe comorbid conditions, or those who are 45.5 Kg / 100 lbs or more over their estimated ideal weight. Prior bariatric surgery. Type I diabetes patients. Participating in another ongoing clinical study with concomitant diagnostic or therapeutic intervention that would reasonably be expected to alter patterns of care, use of medications or the outcomes under study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>